Ag85B-ESAT-6 fusion protein vaccine (Statens Serum Institut)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAg85B-ESAT-6 fusion protein vaccine (Statens Serum Institut)
Drug Alias NameAg85B-ESAT-6/CAF01
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsTuberculosis, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesStatens Serum Institut
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStatens Serum Institut
Active IndicationsN/A
Inactive IndicationsTuberculosis, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A